Antiretroviral Therapy Adherence: Testing a Social Context Model Among Black Men Who Use Illicit Drugs

Journal of the Association of Nurses in AIDS Care

Volumn 22, Issue 2, 2011, Pages 100-127

  Phillips, J Craig ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Causal modeling; Ecosocial theory; HIV; Path analysis; Social epidemiology

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; STREET DRUG;

ADDICTION; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEGRO; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; MALE; MODELS, PSYCHOLOGICAL; PATIENT COMPLIANCE; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 79951576334     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2010.07.008     Document Type: Article

References (58)

1. Altice F.L., Mostashari F., Freidland G.H. Trust and the acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome 2001, 28:47-58.
2. Asher H.B. Causal modeling 1983, Sage, Beverly Hills, CA. 2nd ed.
3. Bakken S., Holzemer W.L., Portillo C.J., Grimes R., Welch J., Wantland D. Utility of a standardized nursing terminology to evaluate dosage and tailoring of an HIV/AIDS adherence intervention. Journal of Nursing Scholarship 2005, 37:251-257. 10.1111/j.1547-5069.2005.00043.x.
4. Bodenlos J.S., Grothe K.B., Whitehead D., Konkle-Parker D.J., Jones G.N., Brantley P.J. Attitudes toward health care providers and appointment attendance in HIV/AIDS patients. Journal of the Association of Nurses in AIDS Care 2007, 18:65-73. 10.1016/j.jana.2007.03.002.
5. Bogart L.M., Catz S.L., Kelly J.A., Benotsch E.G. Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Medical Decision Making 2001, 21:28-36. 10.1177/0272989x0102100104.
6. Bogart L.M., Wagner G., Galvan F.H., Banks D. Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among African American men with HIV. Journal of Acquired Immune Deficiency Syndrome 2010, 53:648-655. 10.1097/QAI.0b013e3181c57dbc.
7. Buchanan D.R. An ethic for health promotion: Rethinking the sources of human well-being 2000, Oxford University Press, New York, NY.
8. Burris S., Blankenship K.M., Donoghoe M., Sherman S., Vernick J.S., Case P., Koester S., et al. Addressing the " risk environment" for injection drug users: The mysterious case of the missing cop. Milbank Quarterly 2004, 82:125-156. 10.1111/j.0887-378X.2004.00304.x.
9. Carmalt J., Zaidi S. The right to health in the United States of America: What does it mean? 2004, Center for Economic and Social Rights, Madrid, Spain, Retrieved from. http://www.cesr.org/downloads/Right%20to%20Health%20in%20USA%202004.pdf.
10. Chesney M.A. The elusive gold standard: Future perspectives for HIV adherence assessment and intervention. Journal of Acquired Immune Deficiency Syndrome 2006, 43(Suppl. 1):149-155.
11. Chesney M.A., Farmer P., Leandre F., Malow R., Starace F. Human immunodeficiency virus and acquired immune deficiency syndrome. World Health Organization, Adherence to long term therapies: Evidence for action 2003, World Health Organization, Geneva, Switzerland, Retrieved from. http://whqlibdoc.who.int/publications/2003/9241545992.pdf.
12. Chesney M.A., Ickovics J.R., Chambers D.B., Gifford A.L., Neidig J., Zwickl B., Wu A.W. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care 2000, 12:255-266. 10.1080/09540120050042891.
13. Cohen J. Statistical power analysis for the behavioral sciences 1988, Lawrence Erlbaum, Hillsdale, NJ.
14. Cohen J., Cohen P., West S.G., Aiken L.S. Applied multiple regression/correlation analysis for the behavioral sciences 2003, Erlbaum, Mahwah, NJ. 3rd ed.
15. Dawson-Rose C., Shade S.B., Lum P.J., Knight K.R., Parsons J.T., Purcell D.W. Health care experiences of HIV positive injection drug users. The Journal of Multicultural Nursing and Health 2005, 11:23-30.
16. Dilorio C., McCarty F., DePadilla L., Resnicow K., Holstad M.M., Yeager K., Lundberg B., et al. Adherence to antiretroviral medication regimens: A test of a psychosocial model. AIDS and Behavior 2009, 13:10-22. 10.1007/s10461-007-9318-4.
17. Dilorio C., Resnicow K., McDonnell M., Soet J., McCarty F., Yeager K. Using motivational interviewing to promote adherence to antiretroviral medications: A pilot study. Journal of the Association of Nurses in AIDS Care 2003, 14:52-62. 10.1177/1055329002250996.
18. Feaster D.J., Brincks A.M., Mitrani V.B., Prado G., Schwartz S.J., Szapocznik J. The efficacy of structural ecosystems therapy for HIV medication adherence with African American women. Journal of Family Psychology 2010, 24:51-59. 10.1037/a0017954.
19. Franks P., Meunnig P., Lubetkin E., Jia H. The burden of disease associated with being African-American in the United States and the contribution of socio-economic status. Social Science and Medicine 2006, 62:2469-2478. 10.1016/j.socscimed.2005.10.035.
20. Gonzalez J.S., Penedo F.J., Antoni M.H., Duran R.E., Fernandez M.I., McPherson-Baker S., Schneiderman N. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology 2004, 23:413-418.
21. Grootaert, C., Narayan, D., Jones, V.N., & Woolcock, M. (2004). Measuring social capital: An integrated questionnaire. World Bank Working Paper No. 18, Washington, DC: The World Bank.
22. Halkitis P.N., Kutnick A.H., Slater S. The social realities of adherence to protease inhibitor regimens: Substance use, health care and psychological states. Journal of Health Psychology 2005, 10:545-558. 10.1177/1359105305053422.
23. Halkitis P.N., Parsons J.T., Wolitski R.J., Remien R.H. Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically diverse sample of men who have sex with men. AIDS Care 2003, 15:89-102. 10.1080/095401221000039798.
24. Hartzell J.D., Spooner K., Howard R., Wegner S., Wortmann G. Race and mental health diagnosis are risk factors for highly active antiretroviral therapy failure in a military cohort despite equal access to care. Journal of Acquired Immune Deficiency Syndrome 2007, 44:411-416.
25. Hintze J. NCSS and PASS 2004, Number Cruncher Statistical Systems, Kaysville, UT.
26. HIV InSite Dealing with drug side effects 2006, Retrieved from. http://hivinsite.ucsf.edu/insite?page=pb-treat-04-00.
27. Holzemer W.L., Henry S.B., Portillo C.J., Miramontes H. The client adherence profiling-intervention tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: A pilot study. Journal of the Association of Nurses in AIDS Care 2000, 11:36-44. 10.1016/S1055-3290(06)60420-2.
28. Horowitz M., Alder N., Kegeles S. A scale for measuring the occurrence of positive states of mind: A preliminary report. Psychosomatic Medicine 1988, 50:477-483.
29. Howitt, M. (1829). The Spider and the Fly (Poem). Retrieved from http://www.love-poems.me.uk/howitt_the_spider_and_the_fly_funny.htm.
30. Johnson M.O., Chesney M.A., Goldstein R.B., Remien R.H., Catz S., Gore-Felton C., Morin S.F., et al. Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model. AIDS Patient Care and STDs 2006, 20:258-268. 10.1089/apc.2006.20.258.
31. Johnson M.O., Gamarel K.E., Dawson-Rose C. Changing HIV treatment expectancies: A pilot study. AIDS Care 2006, 18:550-553. 10.1080/09540120500241439.
32. Joint United Nations Programme on HIV/AIDS AIDS outlook: World AIDS Day 2008 2008, UNAIDS, Geneva, Switzerland, Retrieved from. http://data.unaids.org/pub/Report/2008/20081128_aids_outlook09_en.pdf.
33. Joint United Nations Programme on HIV/AIDS Report on the global HIV/AIDS epidemic 2008 2008, UNAIDS, Geneva, Switzerland, Retrieved from. http://data.unaids.org/pub/GlobalReport/2008/JC1510_2008GlobalReport_en.zip.
34. Kessler R.C., Andrews G., Colpe L.J., Hiripi E., Mroczek D.K., Normand S.L.T., Zaslavsky A.M., et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine 2003, 32:959-976. 10.1017/S0033291702006074.
35. Kidder D.P., Wolitski R.J., Royal S., Aidala A., Courtney-Quirk C., Holtgrave D.R., et al. Access to housing as a structural intervention for homeless and unstably housed people living with HIV: Rationale, methods, and implementation of the housing and health study. AIDS and Behavior 2007, 11(Suppl 2):149-161. Housing and Health Study Team. 10.1007/s10461-007-9249-0.
36. Knowlton A.R., Arnsten J.H., Eldred L.J., Wilkinson J.D., Shade S.B., Bohnert A.S., Purcell D.W., et al. Antiretroviral use among active injection-drug users: The role of patient-provider engagement and structural factors. AIDS Patient Care and STDs 2010, 24:421-428. 10.1089/apc.2009.0240.
37. Krawczyk C.S., Funkhouser E., Kilby J.M., Vermund S.H. Delayed access to HIV diagnosis and care: Special concerns for the Southern United States. AIDS Care 2006, 18(Suppl. 1):35-44. 10.1080/09540120600839280.
38. Krieger N. Epidemiology and the web of causation: Has anyone seen the spider?. Social Science & Medicine 1994, 39:887-903. 10.1016/0277-9536(94)90202-X.
39. Krieger N. Proximal, distal, and the politics of causation: What's level got to do with it?. American Journal of Public Health 2008, 98:221-230. 10.2105/AJPH.2007.111278.
40. Krupat E., Putnam S.M., Yeager C. The fit between doctors and patient: Can it be measured?. Journal of General Internal Medicine 1996, 11(Suppl. 1):134.
41. Lane S.D., Rubinstein R.A., Keefe R.H., Webster N., Cibula D.A., Rosenthal A., Dowdell J. Structural violence and racial disparity in HIV transmission. Journal of Health Care for the Poor and Underserved 2004, 15:319-335.
42. Lima V.D., Johnston K., Hogg R.S., Levy A.R., Harrigan P.R., Anema A., Montaner J.S.G. Expanded access to highly active antiretroviral therapy: A potentially powerful strategy to curb the growth of the HIV epidemic. Journal of Infectious Diseases 2008, 198:59-67. 10.1086/588673.
43. Mitchell A.D., Bossert T.J. Measuring dimensions of social capital: Evidence from surveys in poor communities in Nicaragua. Social Science and Medicine 2007, 64:50-63. 10.1016/j.socscimed.2006.08.021.
44. Montaner J.S.G., Hogg R., Wood E., Kerr T., Tyndall M., Levy A.R. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006, 368:531-536.
45. Moss, A., R., Hahn, J.A., Perry, S., Charlebois, E.D., Guzman, D., Clark, R., & Bangsberg, D.R. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39, 1190-1198. doi:10.1086/424008.
46. Muthén B., Muthén L. Mplus (Version 6) 2010, Statmodel, Los Angeles, CA.
47. Oggins J. Notions of HIV and medication among multiethnic people living with HIV. Health and Social Work 2003, 28:53-62.
48. Penrod J., Preston D.B., Cain R.E., Starks M.T. A discussion of chain referral as a method of sampling hard-to-reach populations. Journal of Transcultural Nursing 2003, 14:100-107.
49. Poundstone K.E., Strathdee S.A., Celentano D.D. The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome. Epidemiologic Reviews 2004, 26:22-35.
50. Sledjeski E.M., Delahanty D.L., Bogart L.M. Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4+ counts in people living with HIV. AIDS Patient Care and STDs 2005, 19:728-736. 10.1089/apc.2005.19.72.
51. Stirratt M.J., Remien R.H., Smith A., Copeland O.Q., Dolezal C., Kreiger D. The role of HIV serostatus disclosure in antiretroviral medication adherence. AIDS and Behavior 2006, 10:483-493. the SMART Couples Study Team. 10.1007/s10461-006-9106-6.
52. Szapocznik J., Feaster D.J., Mitrani V.B., Prado G., Smith L., Robinson-Batista C., Robbins M.S., et al. Structural ecosystems therapy for HIV-seropositive African American women: Effects on psychological distress, family hassles, and family support. Journal of Consulting and Clinical Psychology 2004, 72:288-303.
53. Szreter S., Woolcock M. Health by association? Social capital, social theory, and the political economy of public health. International Journal of Epidemiology 2004, 33:650-667. 10.1093/ije/dyh013.
54. Thom D., Ribisl K.M., Stewart A.L., Luke D.A. Further validation and reliability of the Trust in Physician Scale. Medical Care 1999, 37:510-517.
55. Tucker J.S., Orlando M., Burnam A., Sherbourne C.D., Kung F., Gifford A.L. Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychology 2004, 23:363-370.
56. Wagner G.J., Remien R.H., Carballo-Diéguez A., Dolezal C. Correlates of adherence to combination antiretroviral therapy among members of HIV-positive mixed status couples. AIDS Care 2002, 14:105-109. 10.1080/09540120220097973.
57. Ware N.C., Wyatt M.A., Tugenberg T. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs. Social Science and Medicine 2005, 61:565-576. 10.1016/j.socscimed.2004.12.015.
58. Yun L.W., Maravi M., Kobayashi J.S., Barton P.L., Davidson A.J. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. Journal of Acquired Immune Deficiency Syndrome 2005, 38:432-438.